Locoid 0.1% scalp lotion

国: イギリス

言語: 英語

ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)

有効成分:

Hydrocortisone butyrate

から入手可能:

Neon Healthcare Ltd

ATCコード:

D07AB02

INN（国際名）:

Hydrocortisone butyrate

投薬量:

1mg/1ml

医薬品形態:

Cutaneous solution

投与経路:

Cutaneous

クラス:

No Controlled Drug Status

処方タイプ:

Valid as a prescribable product

製品概要:

BNF: 13040000; GTIN: 5013346026653

情報リーフレット

_S0844 LEAFLET Locoid 20200302 _
PACKAGE LEAFLET: INFORMATION FOR USER
LOCOID
® SCALP LOTION
(hydrocortisone butyrate)
Your medicine is known as Locoid Scalp Lotion but will be referred
to as Locoid throughout the following leaflet.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor, pharmacist
or nurse.

This medicine has been prescribed for you only. Do not pass it
on to others. It may harm them, even if their signs of illness are
the same as yours.

If you get any side effects, talk to your doctor, pharmacist or
nurse. This includes any possible side effects not listed in this
leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Locoid is and what it is used for
2.
What you need to know before you use Locoid
3.
How to use Locoid
4.
Possible side effects
5.
How to store Locoid
6.
Contents of the pack and other information
1.
WHAT LOCOID IS AND WHAT IT IS USED FOR
Locoid contains the active substance hydrocortisone butyrate. This
is a corticosteroid which when made up as a lotion is for use on the
skin. This is known as topical application. Topical corticosteroids
are ranked as mildly potent, moderately potent, potent and very
potent; Locoid is classed as potent. Topical corticosteroids are able
to reduce the inflammation caused by a variety of skin conditions,
and so allow it to get better. They can also affect the cause of the
condition, which can lead to its healing.
Locoid is indicated in adults, children and infants. It is used to
treat
a variety of skin conditions such as eczema and dermatitis (itching)
of all types, but it is used in particular in the treatment of
psoriasis of
the scalp. This is a condition resulting in thickening of areas of the
scalp. It can also be used for the treatment of seborrhoea capitis, a
condition causing redness and inflammation of the scalp, and
scaling of the scalp with crusted patches,

製品の特徴

OBJECT 1
LOCOID SCALP LOTION
Summary of Product Characteristics Updated 22-Sep-2016 | Leo
Laboratories Limited
1. Name of the medicinal product
Locoid Scalp Lotion
2. Qualitative and quantitative composition
Locoid Scalp Lotion contains 0.1% w/v hydrocortisone butyrate.
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Cutaneous solution.
The product is a clear, colourless solution.
4. Clinical particulars
4.1 Therapeutic indications
Locoid Scalp Lotion is indicated in adults, children and infants. The
product is recommended for clinical
use in the treatment of scalp conditions responsive to topical
corticosteroids e.g. eczema, dermatitis and
psoriasis.
Topical corticosteroids are not generally indicated in psoriasis but
may be acceptable in psoriasis
excluding widespread plaque psoriasis provided warnings are given; see
section 4.4 Special warnings and
precautions for use.
4.2 Posology and method of administration
Posology
_Adults and older people_
The same dose is used for adults and older people, as clinical
evidence would indicate that no special
dosage regimen is necessary in older people.
_Paediatric population_
Long term treatment should be avoided where possible.
_Infants_
Therapy should be limited if possible to a maximum of seven days.
Method of administration
For cutaneous use on the scalp.
Dosage: To be applied evenly and sparingly no more than twice daily
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
This preparation is contraindicated in the presence of untreated viral
or fungal infections, tubercular or
syphilitic lesions, peri-oral dermatitis, acne vulgaris and rosacea
and in bacterial infections unless used in
connection with appropriate chemotherapy.
4.4 Special warnings and precautions for use
As with all corticosteroids, application to the face, flexures and
other areas of thin skin may cause skin
atrophy and increased absorption and should be avoided.
Topical corticosteroids may be hazardous in psoriasis